We examine patterns amongst data across multiple years in this final installment of our supplemental diagnosis code blog series.
HCC Failure Rate Groups and the Supplemental Diagnosis File
In this follow-up blog on supplemental diagnosis codes, we take a deep dive into failure rates, how they are calculated, and the impact they have on the risk adjustment data validation process.
RaLytics Comments on the 2024 ACA Proposed Rule
In response to the notice of benefit and payment parameters for ACA published by HHS, RaLytics has a number of suggestions on how to ensure the ACA risk adjustment process is more efficient and equitable for everyone.
Risk Adjustment in ACA Marketplaces: What to Watch out for in Benefit Years 2024 and Beyond
The 2024 Notice of Benefit and Payment Parameters recently released by HHS proposes several changes with significant implications for risk adjustment within the ACA marketplace.
The Importance of Supplemental Diagnosis Code Submissions for ACA Risk Adjustment
The submission of supplemental diagnosis codes can have a significant impact on payment within the Affordable Care Act Risk Adjustment program.
Risk Adjustment in ACA Marketplaces: The 2023 Final Rule
HHS has published the final 2023 Notice of Benefit and Payment Parameters, implementing significant changes to the risk adjustment program for qualified health plans.
Risk Adjustment in ACA Marketplaces: What to Watch Out For in Benefit Years 2023 and Beyond
Changes in the proposed rule for the ACA marketplace with regards to risk adjustment in future benefit years portend critical impacts to participating health plans.